Related Experiment Video
Updated: Jan 23, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Sonodynamic therapy inhibits palmitate-induced beta cell dysfunction via PINK1/Parkin-dependent mitophagy
Tian Guo1, Tianyang Liu1, Yun Sun1
1Department of Pathophysiology, Harbin Medical University, Harbin, 150081, China.
Abstract:
In type 2 diabetes mellitus (T2DM), the overload of glucose and lipids can promote oxidative stress and inflammatory responses and contribute to the failure of beta cells. However, therapies that can modulate the function of beta cells and thus prevent their failure have not been well explored. In this study, beta cell injury model was established with palmitic acid (PA) to simulate the lipotoxicity (high-fat diet) found in T2DM. Sonodynamic therapy (SDT), a novel physicochemical treatment, was applied to treat injured beta cells. We found that SDT had specific effects on mitochondria and induced transient large amount of mitochondrial reactive oxygen species (ROS) production in beta cells. SDT also improved the morphology and function of abnormal mitochondria, inhibited inflammatory response and reduced beta cell dysfunction. The improvement of mitochondria was mediated by PINK1/Parkin-dependent mitophagy. Additionally, SDT rescued the transcription of PINK1 mRNA which was blocked by PA treatment, thus providing abundant PINK1 for mitophagy. Moreover, SDT also increased insulin secretion from beta cells. The protective effects of SDT were abrogated when mitophagy was inhibited by cyclosporin A (CsA). In summary, SDT potently inhibits lipotoxicity-induced beta cell failure via PINK1/Parkin-dependent mitophagy, providing theoretical guidance for T2DM treatment in aspects of islet protection.
Insights
Sonodynamic therapy (SDT) protects beta cells from lipotoxicity in type 2 diabetes mellitus (T2DM). SDT promotes mitophagy, improving mitochondrial function and insulin secretion, offering a novel therapeutic approach for T2DM islet protection.
Area of Science:
- Endocrinology
- Cell Biology
- Biomedical Engineering
Background:
- Type 2 diabetes mellitus (T2DM) involves beta cell dysfunction due to glucose and lipid overload, leading to oxidative stress and inflammation.
- Current therapies for T2DM often overlook strategies to modulate beta cell function and prevent failure.
- Lipotoxicity, simulating a high-fat diet, is a key factor in beta cell failure.
Purpose of the Study:
- To investigate the efficacy of Sonodynamic therapy (SDT) in protecting beta cells from lipotoxicity-induced injury.
- To elucidate the underlying mechanisms of SDT's protective effects on beta cells.
- To explore SDT as a potential therapeutic strategy for T2DM islet protection.
Main Methods:
- Established a beta cell injury model using palmitic acid (PA) to mimic T2DM lipotoxicity.
- Applied Sonodynamic therapy (SDT) to treat the injured beta cells.
- Investigated mitochondrial function, reactive oxygen species (ROS) production, inflammatory responses, and insulin secretion.
- Analyzed the role of PINK1/Parkin-dependent mitophagy and its regulation by SDT.
- Utilized cyclosporin A (CsA) to inhibit mitophagy and assess its impact on SDT's protective effects.
Main Results:
- SDT induced transient mitochondrial reactive oxygen species (ROS) production in beta cells.
- SDT improved mitochondrial morphology and function, inhibited inflammation, and reduced beta cell dysfunction.
- The protective effects were mediated by PINK1/Parkin-dependent mitophagy, with SDT rescuing PINK1 mRNA transcription.
- SDT significantly increased insulin secretion from beta cells.
- Inhibition of mitophagy by CsA abrogated the protective effects of SDT.
Conclusions:
- SDT effectively protects against lipotoxicity-induced beta cell failure in a T2DM model.
- PINK1/Parkin-dependent mitophagy is a key mechanism underlying SDT's protective action.
- SDT enhances mitochondrial quality control and insulin secretion, offering a promising therapeutic avenue for T2DM.
- This study provides a theoretical basis for using SDT in islet protection strategies for T2DM management.
More Related Videos
Related Concept Videos
Feedback Inhibition
Gene Therapy
Frequency-dependent Selection
Enzyme Inhibition
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Induced Pluripotent Stem Cells

